Mills R - Search Results

1

Chronic neurodegenerative disease associated with HTLV-II infection.

Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G. Hjelle B, et al. Among authors: mills r. Lancet. 1992 Mar 14;339(8794):645-6. doi: 10.1016/0140-6736(92)90797-7. Lancet. 1992. PMID: 1347339

2

Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population.

Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. Hjelle B, et al. Among authors: mills r. J Infect Dis. 1991 Mar;163(3):435-40. doi: 10.1093/infdis/163.3.435. J Infect Dis. 1991. PMID: 1995717

3

Transmission of HTLV-II via blood transfusion.

Hjelle B, Mills R, Mertz G, Swenson S. Hjelle B, et al. Among authors: mills r. Vox Sang. 1990;59(2):119-22. doi: 10.1111/j.1423-0410.1990.tb05023.x. Vox Sang. 1990. PMID: 2238562

4

Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors.

Hjelle B, Mills R, Goldsmith C, Swenson SG, Cyrus S. Hjelle B, et al. Among authors: mills r. J Clin Microbiol. 1992 Aug;30(8):2195-9. doi: 10.1128/jcm.30.8.2195-2199.1992. J Clin Microbiol. 1992. PMID: 1500534 Free PMC article.

5

Serologic distinction between human T-lymphotropic virus (HTLV) type I and HTLV type II.

Hjelle B, Cyrus S, Swenson S, Mills R. Hjelle B, et al. Among authors: mills r. Transfusion. 1991 Oct;31(8):731-6. doi: 10.1046/j.1537-2995.1991.31892023499.x. Transfusion. 1991. PMID: 1926318

6

Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA. Davis LE, et al. Among authors: mills rg. Neurology. 1992 Sep;42(9):1736-9. doi: 10.1212/wnl.42.9.1736. Neurology. 1992. PMID: 1513462

7

HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells.

Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, Davis LE, Merlin TL. Palmer DL, et al. Among authors: mills rg. Am J Med. 1994 Sep;97(3):289-95. doi: 10.1016/0002-9343(94)90012-4. Am J Med. 1994. PMID: 8092178

8

Glucose inhibition of human fibroblast proliferation and response to growth factors is prevented by inhibitors of aldose reductase.

Sibbitt WL Jr, Mills RG, Bigler CF, Eaton RP, Griffey RH, Vander Jagt DL. Sibbitt WL Jr, et al. Among authors: mills rg. Mech Ageing Dev. 1989 Mar;47(3):265-79. doi: 10.1016/0047-6374(89)90038-9. Mech Ageing Dev. 1989. PMID: 2497284

9

Comparison of the antiviral activities of 3'-azido-3'-deoxythymidine (AZT) and gossylic iminolactone (GIL) against clinical isolates of HIV-1.

Royer RE, Mills RG, Young SA, Vander Jagt DL. Royer RE, et al. Among authors: mills rg. Pharmacol Res. 1995 Jan;31(1):49-52. doi: 10.1016/1043-6618(95)80047-6. Pharmacol Res. 1995. PMID: 7540302

10

Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.

Royer RE, Mills RG, Deck LM, Mertz GJ, Vander Jagt DL. Royer RE, et al. Among authors: mills rg. Pharmacol Res. 1991 Dec;24(4):407-12. doi: 10.1016/1043-6618(91)90045-y. Pharmacol Res. 1991. PMID: 1805194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,533 results

Search Page

Filters